MedTrace Logo

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

NCT04421716 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-05-05

No results posted yet for this study

Summary

The primary objective of this research is to investigate the bioavailability of curcumin (CURC) and ursolic acid (UA) in a phase I clinical trial in healthy men and obtain biological material for bioavailability analysis.

Conditions

  • Bioavailability of Phytonutrients

Interventions

DRUG

Ursolic Acid

Ursolic Acid 150mg

DRUG

Curcumin

Curcumin 600mg

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Michael A Liss, MD · University of Texas Health at San Antonio

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2020-11-30
Completion
2021-04-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04421716 on ClinicalTrials.gov